Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co.,Ltd. (HKG: 1349)
Hong Kong
· Delayed Price · Currency is HKD 1.790
0.00 (0.00%)
At close: Sep 5, 2024
Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co.,Ltd. Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '24 Jun 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
| Net Income | 110.66 | 108.63 | 138 | 213.3 | 164.66 | 227.36 | Upgrade
|
| Depreciation & Amortization | 49.85 | 53.73 | 80.97 | 60.85 | 53.61 | 56.68 | Upgrade
|
| Other Amortization | 14 | 8.51 | 1.22 | 0.96 | 1.23 | 2.99 | Upgrade
|
| Loss (Gain) From Sale of Assets | 1.04 | -0.3 | -1.92 | -1.78 | -4.6 | -0.7 | Upgrade
|
| Asset Writedown & Restructuring Costs | 5.74 | 5.78 | 1.01 | 0.35 | 0.41 | 5.29 | Upgrade
|
| Loss (Gain) From Sale of Investments | 4.35 | 4.35 | 1.28 | -20.76 | -17.23 | -11.06 | Upgrade
|
| Stock-Based Compensation | - | -1.84 | 7.69 | 64.97 | - | - | Upgrade
|
| Provision & Write-off of Bad Debts | 31.19 | 23.9 | -2.41 | 5.78 | 5.91 | 2.52 | Upgrade
|
| Other Operating Activities | 4.68 | 6.23 | -0.28 | -6.13 | 12.81 | 3.4 | Upgrade
|
| Change in Accounts Receivable | 107.19 | -10.47 | -89.73 | -95.37 | -83.54 | -122.9 | Upgrade
|
| Change in Inventory | -6.51 | -6.57 | -5.84 | 0.32 | -5.41 | -4.33 | Upgrade
|
| Change in Accounts Payable | -76.99 | -74.05 | 48.72 | 72.56 | -2.54 | 134.12 | Upgrade
|
| Change in Unearned Revenue | -29.91 | -31.89 | -6.76 | -9.89 | -7.52 | -7.48 | Upgrade
|
| Operating Cash Flow | 207.42 | 71.02 | 165.27 | 268.9 | 113 | 269.23 | Upgrade
|
| Operating Cash Flow Growth | - | -57.03% | -38.54% | 137.96% | -58.03% | 49.71% | Upgrade
|
| Capital Expenditures | -53.14 | -98.97 | -87.3 | -120.12 | -42.41 | -40.39 | Upgrade
|
| Sale of Property, Plant & Equipment | -0.11 | 0.68 | 1.44 | 1.71 | 12.03 | 2.62 | Upgrade
|
| Divestitures | - | - | - | 6.34 | - | 6.8 | Upgrade
|
| Investment in Securities | 20.91 | 52.91 | -10.88 | -243.6 | -16.15 | 9.83 | Upgrade
|
| Investing Cash Flow | -32.34 | -45.38 | -96.75 | -355.67 | -46.54 | -21.14 | Upgrade
|
| Short-Term Debt Issued | - | - | 101 | - | 51.06 | 151.57 | Upgrade
|
| Total Debt Issued | - | - | 101 | - | 51.06 | 151.57 | Upgrade
|
| Short-Term Debt Repaid | - | -100 | - | - | -200 | -150 | Upgrade
|
| Long-Term Debt Repaid | - | -9.38 | -9.52 | -7.5 | -5.31 | -6.2 | Upgrade
|
| Total Debt Repaid | -109.9 | -109.38 | -9.52 | -7.5 | -205.31 | -156.2 | Upgrade
|
| Net Debt Issued (Repaid) | -109.9 | -109.38 | 91.48 | -7.5 | -154.26 | -4.64 | Upgrade
|
| Issuance of Common Stock | - | 66.86 | - | - | 996.19 | - | Upgrade
|
| Repurchase of Common Stock | - | - | -8.7 | -40.82 | - | - | Upgrade
|
| Common Dividends Paid | -76.15 | -76.15 | -71.04 | -52.15 | -69.77 | -70.2 | Upgrade
|
| Other Financing Activities | 2.39 | -0.31 | -0.14 | -0.69 | -18.32 | -184.73 | Upgrade
|
| Financing Cash Flow | -183.66 | -118.98 | 11.61 | -101.16 | 753.85 | -259.57 | Upgrade
|
| Foreign Exchange Rate Adjustments | -0.07 | -0.07 | 0.29 | -0.07 | -0.22 | 0.06 | Upgrade
|
| Net Cash Flow | -8.65 | -93.41 | 80.42 | -188.01 | 820.09 | -11.42 | Upgrade
|
| Free Cash Flow | 154.28 | -27.95 | 77.96 | 148.78 | 70.59 | 228.85 | Upgrade
|
| Free Cash Flow Growth | - | - | -47.60% | 110.76% | -69.15% | 62.45% | Upgrade
|
| Free Cash Flow Margin | 20.96% | -3.29% | 7.56% | 13.05% | 8.47% | 22.23% | Upgrade
|
| Free Cash Flow Per Share | 0.15 | -0.03 | 0.08 | 0.14 | 0.07 | 0.25 | Upgrade
|
| Cash Income Tax Paid | 46.87 | 33.53 | 68.66 | 68.12 | 66.09 | 109.73 | Upgrade
|
| Levered Free Cash Flow | 130.03 | 18.64 | 86.7 | 116.02 | 33.36 | 149.01 | Upgrade
|
| Unlevered Free Cash Flow | 130.98 | 20.56 | 87.67 | 116.68 | 36.86 | 152.95 | Upgrade
|
| Change in Net Working Capital | -77.1 | -10.92 | -13.79 | -8.31 | 64.79 | 10.71 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.